Physicians’ Education Resource® Presents the 3rd Annual European Congress on Hematology™: Focus on Lymphoid Malignancies
CRANBURY, N.J.--(BUSINESS WIRE)--Oct 4, 2018--Physicians’ Education Resource ® (PER ® ), the leading provider of oncology and hematology continuing medical education (CME), will host the third annual European Congress on Hematology™: Focus on Lymphoid Malignancies from Oct. 12-13 at The Westin Paris-Vendôme in Paris, France. The program will be chaired by Anas Younes, M.D., professor and chief, lymphoma service, division of hematologic oncology, Memorial Sloan Kettering Cancer Center in New York City, and co-chaired by Paolo Ghia, M.D., Ph.D., associate professor, Università Vita-Salute San Raffaele, director, strategic research program on chronic lymphocytic leukemia, IRCCS San Raffaele Scientific Institute, Milan, Italy, and Gilles A. Salles, M.D., Ph.D., university professor, head of hematology, Claude Bernard University of Lyon, Hospices Civils de Lyon, France.
“We are excited to share important clinical and scientific research with health care professionals in Europe,” said Phil Talamo, president of PER ®. “This congress brings together leading experts from several universities and medical centers across Europe and the United States to create a multidisciplinary collaboration with a goal of enhancing the treatment of hematologic and lymphoid malignancies.”
Designed for medical oncologist and other healthcare professionals, the third annual European Congress on Hematology™: Focus on Lymphoid Malignancies will discuss major developments in treatment and management of patients with hematologic malignancies. Attendees will also be able to enhance their skills to contextualize the wealth of emerging data on how to treat hematologic and lymphoid malignancies, update their clinical decision-making based upon individual patient and tumor characteristics and mitigation of adverse events, and learn how to apply novel management strategies to their practices to improve patient outcomes. The conference will also feature interactive discussions in which participants will be challenged to engage directly with renowned faculty to share their perspectives, experiences, and methods to address clinical challenges in the management of lymphoid malignancies.
For more information and to register, please visit https://www.gotoper.com/conferences/ech/meetings/3rd-annual-european-congress-on-hematology-focus-on-lymphoid-malignancies.
About Physicians’ Education Resource ® (PER ® )
Since 1995, PER ® has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER ® initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas and continues to grow its therapeutic reach outside of oncology. While continuing to expand into topics outside of oncology, PER ® remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. In 2018, PER ® will develop and implement 21 historic annual legacy conferences in the United States and Europe, along with many renowned online learning formats. PER ® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER ® is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181004005486/en/
CONTACT: PER® Media
Alexandra Ventura, 609-716-7777, ext. 121
John Patricolo, 609-325-4630, ext. 133
KEYWORD: UNITED STATES EUROPE NORTH AMERICA FRANCE NEW JERSEY
INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS ONCOLOGY RESEARCH SCIENCE
SOURCE: Physicians’ Education Resource
Copyright Business Wire 2018.
PUB: 10/04/2018 10:31 AM/DISC: 10/04/2018 10:31 AM